Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Brian Sauer

Concepts (394)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
42
2024
1169
5.810
 Why?
Antirheumatic Agents
24
2024
304
5.320
 Why?
Veterans
32
2023
1603
3.700
 Why?
Spondylitis, Ankylosing
5
2020
43
2.360
 Why?
Hyperkalemia
3
2023
35
2.200
 Why?
Veterans Health
8
2023
189
2.080
 Why?
United States Department of Veterans Affairs
12
2021
768
1.840
 Why?
Methotrexate
10
2021
240
1.780
 Why?
Spondylarthritis
3
2020
50
1.240
 Why?
Natural Language Processing
4
2023
103
1.210
 Why?
Drug-Related Side Effects and Adverse Reactions
5
2019
257
1.160
 Why?
Rheumatology
2
2020
133
1.160
 Why?
Biological Products
6
2021
252
1.140
 Why?
Registries
18
2024
2385
1.110
 Why?
Tumor Necrosis Factor-alpha
6
2024
1217
1.080
 Why?
Medication Adherence
4
2019
539
1.010
 Why?
Drug Substitution
3
2021
63
0.900
 Why?
Psoriasis
2
2015
112
0.820
 Why?
Arthritis, Psoriatic
3
2019
15
0.800
 Why?
Lymphoma, Follicular
2
2021
56
0.790
 Why?
Aged
46
2024
25947
0.780
 Why?
Sulfasalazine
3
2019
22
0.770
 Why?
Misoprostol
1
2022
15
0.740
 Why?
Hydroxychloroquine
3
2019
63
0.730
 Why?
HLA-B27 Antigen
3
2019
16
0.720
 Why?
Lung Diseases, Interstitial
6
2024
660
0.700
 Why?
Humans
97
2024
144957
0.690
 Why?
Middle Aged
47
2024
35928
0.670
 Why?
Databases, Factual
7
2018
1486
0.660
 Why?
United States
31
2023
15988
0.650
 Why?
Electronic Health Records
6
2023
1177
0.640
 Why?
Cohort Studies
16
2024
5965
0.640
 Why?
Rituximab
2
2021
210
0.640
 Why?
Infliximab
3
2016
108
0.630
 Why?
Insurance Claim Review
2
2017
83
0.610
 Why?
Practice Patterns, Physicians'
5
2019
1358
0.610
 Why?
Pharmaceutical Services
2
2019
78
0.610
 Why?
Analgesics, Opioid
5
2020
1143
0.590
 Why?
Buprenorphine
1
2023
191
0.590
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
338
0.590
 Why?
Prostatic Neoplasms, Castration-Resistant
1
2019
53
0.580
 Why?
Arthritis
2
2021
96
0.580
 Why?
Algorithms
5
2020
1839
0.580
 Why?
Datasets as Topic
1
2019
122
0.570
 Why?
Treatment Outcome
19
2024
11695
0.560
 Why?
Anemia, Iron-Deficiency
1
2019
62
0.560
 Why?
Severity of Illness Index
12
2023
2925
0.550
 Why?
Etanercept
2
2016
60
0.550
 Why?
Antineoplastic Agents, Immunological
1
2020
199
0.540
 Why?
Adalimumab
2
2016
55
0.540
 Why?
Male
54
2024
72406
0.540
 Why?
Iron
2
2021
359
0.520
 Why?
Kidney Failure, Chronic
1
2022
598
0.490
 Why?
Chronic Pain
3
2022
292
0.480
 Why?
Renal Insufficiency, Chronic
2
2021
653
0.470
 Why?
Computer Simulation
4
2020
1026
0.470
 Why?
Drug Monitoring
4
2012
395
0.460
 Why?
Female
49
2024
78376
0.460
 Why?
Delivery of Health Care
2
2022
947
0.460
 Why?
Terminology as Topic
1
2017
255
0.450
 Why?
Healthcare Common Procedure Coding System
1
2014
1
0.440
 Why?
Cross-Over Studies
1
2017
601
0.440
 Why?
Diabetes Mellitus
3
2024
1098
0.430
 Why?
Opioid-Related Disorders
1
2023
601
0.430
 Why?
Risk Factors
23
2024
10792
0.430
 Why?
Polymers
3
2023
499
0.430
 Why?
Research Design
3
2020
1137
0.420
 Why?
Insurance, Pharmaceutical Services
2
2011
24
0.420
 Why?
Adipokines
3
2022
57
0.410
 Why?
Cytokines
5
2024
2065
0.410
 Why?
Narcotics
1
2013
58
0.390
 Why?
Models, Statistical
2
2017
682
0.390
 Why?
Hospitalization
5
2021
2434
0.370
 Why?
Ambulatory Care
2
2014
603
0.370
 Why?
Potassium
2
2023
152
0.370
 Why?
Utah
7
2013
81
0.370
 Why?
Comparative Effectiveness Research
1
2013
170
0.360
 Why?
Pharmaceutical Preparations
3
2022
170
0.360
 Why?
Drug Prescriptions
2
2013
285
0.360
 Why?
Remission Induction
3
2022
308
0.360
 Why?
Medicine
1
2013
125
0.350
 Why?
Emergency Service, Hospital
3
2023
2313
0.350
 Why?
Time Factors
11
2021
7183
0.340
 Why?
Carpal Bones
2
2021
17
0.340
 Why?
Drug Overdose
2
2012
370
0.330
 Why?
Proportional Hazards Models
8
2022
1325
0.330
 Why?
Decision Support Systems, Clinical
2
2012
265
0.320
 Why?
Cardiovascular Diseases
8
2023
2171
0.320
 Why?
Inflammatory Bowel Diseases
1
2015
365
0.320
 Why?
Disease Progression
2
2018
2852
0.320
 Why?
Health Services Accessibility
2
2019
1099
0.310
 Why?
Potentially Inappropriate Medication List
2
2020
16
0.310
 Why?
Adiponectin
4
2024
244
0.310
 Why?
Practice Guidelines as Topic
2
2019
1563
0.310
 Why?
Quality Indicators, Health Care
1
2012
335
0.300
 Why?
C-Reactive Protein
4
2021
417
0.300
 Why?
Retrospective Studies
18
2023
17101
0.300
 Why?
Risk Assessment
10
2021
3676
0.270
 Why?
Kaplan-Meier Estimate
3
2021
966
0.270
 Why?
Body Mass Index
6
2018
2438
0.270
 Why?
Aged, 80 and over
13
2021
8279
0.270
 Why?
Incidence
9
2024
2883
0.260
 Why?
Pneumonia, Bacterial
2
2020
113
0.260
 Why?
Antibodies, Monoclonal
1
2014
1524
0.260
 Why?
Prospective Studies
9
2024
7997
0.260
 Why?
Health Knowledge, Attitudes, Practice
2
2013
1416
0.260
 Why?
ROC Curve
3
2019
615
0.250
 Why?
International Classification of Diseases
4
2023
147
0.250
 Why?
Arthrodesis
3
2021
35
0.240
 Why?
Managed Care Programs
1
2007
140
0.240
 Why?
Multimorbidity
2
2023
63
0.240
 Why?
Predictive Value of Tests
4
2020
2118
0.230
 Why?
Drug Utilization
2
2018
167
0.230
 Why?
Drug Therapy, Combination
2
2019
1048
0.220
 Why?
Propensity Score
3
2020
367
0.220
 Why?
Embryo, Nonmammalian
2
2005
173
0.220
 Why?
Patient Admission
1
2007
218
0.220
 Why?
Gene Targeting
1
2004
82
0.210
 Why?
Data Mining
3
2023
117
0.210
 Why?
Alarmins
1
2024
27
0.210
 Why?
Interleukin-33
1
2024
45
0.210
 Why?
Regression Analysis
3
2018
1003
0.210
 Why?
Adult
16
2022
40506
0.200
 Why?
Embryo, Mammalian
1
2004
232
0.200
 Why?
Wrist
2
2021
60
0.200
 Why?
Wrist Joint
2
2021
71
0.200
 Why?
Poisson Distribution
2
2017
78
0.200
 Why?
Polystyrenes
1
2023
37
0.190
 Why?
Diclofenac
1
2022
14
0.180
 Why?
Follow-Up Studies
7
2021
5417
0.180
 Why?
Neurology
1
2024
114
0.180
 Why?
Weight Loss
2
2018
837
0.180
 Why?
Neoplasms
5
2023
2884
0.180
 Why?
Chemokines
2
2021
218
0.180
 Why?
Blood Sedimentation
2
2019
37
0.180
 Why?
Comorbidity
4
2023
1660
0.180
 Why?
Research Report
1
2022
87
0.180
 Why?
Stroke
2
2021
1258
0.180
 Why?
Rheumatic Diseases
1
2023
97
0.180
 Why?
Confidence Intervals
2
2016
333
0.180
 Why?
Genetic Testing
1
2004
482
0.170
 Why?
Polymerase Chain Reaction
1
2004
1054
0.170
 Why?
Linear Models
3
2018
854
0.170
 Why?
Multivariate Analysis
5
2018
1540
0.170
 Why?
Waldenstrom Macroglobulinemia
1
2021
20
0.170
 Why?
Hospitals, Veterans
3
2018
259
0.170
 Why?
Maintenance Chemotherapy
1
2020
42
0.160
 Why?
Education, Medical
1
2024
276
0.160
 Why?
Prescription Drugs
2
2012
111
0.160
 Why?
Cyclophosphamide
2
2021
266
0.160
 Why?
Communication
2
2024
967
0.160
 Why?
Arthritis, Infectious
1
2021
72
0.160
 Why?
Stem Cells
1
2004
627
0.150
 Why?
Prosthesis-Related Infections
1
2021
99
0.150
 Why?
Pneumonia, Staphylococcal
1
2020
27
0.150
 Why?
SEER Program
1
2020
224
0.150
 Why?
Neoplasm Grading
1
2020
309
0.150
 Why?
Transferrin
1
2019
50
0.150
 Why?
Ferritins
1
2019
69
0.150
 Why?
Ranolazine
1
2018
25
0.140
 Why?
Inappropriate Prescribing
1
2019
64
0.140
 Why?
Bipolar Disorder
1
2021
280
0.140
 Why?
Angina, Stable
1
2018
18
0.140
 Why?
Area Under Curve
1
2019
331
0.140
 Why?
Arthroplasty, Replacement, Hip
1
2021
184
0.140
 Why?
Geriatrics
1
2019
96
0.140
 Why?
Coronary Artery Disease
2
2022
741
0.140
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
192
0.140
 Why?
Professional Practice Location
1
2017
26
0.130
 Why?
Methicillin-Resistant Staphylococcus aureus
2
2020
249
0.130
 Why?
Rheumatologists
1
2017
15
0.130
 Why?
Osteoarthritis
1
2020
196
0.130
 Why?
Random Allocation
1
2018
363
0.130
 Why?
Anti-Citrullinated Protein Antibodies
1
2019
126
0.130
 Why?
Sacroiliitis
1
2017
7
0.130
 Why?
Calcium Channel Blockers
1
2018
165
0.130
 Why?
Reverse Transcriptase Inhibitors
1
2018
87
0.130
 Why?
Heart Failure
2
2021
2323
0.130
 Why?
Brain Ischemia
1
2021
358
0.130
 Why?
Obesity, Abdominal
1
2017
46
0.130
 Why?
Longitudinal Studies
4
2023
2947
0.130
 Why?
Protease Inhibitors
1
2018
102
0.130
 Why?
Bias
3
2013
202
0.130
 Why?
Adrenergic beta-Antagonists
1
2018
250
0.130
 Why?
Data Accuracy
1
2017
65
0.130
 Why?
Population Surveillance
2
2012
485
0.130
 Why?
Disability Evaluation
1
2018
310
0.130
 Why?
Risk Management
2
2007
84
0.130
 Why?
Recovery of Function
1
2021
710
0.130
 Why?
Neoplasm Metastasis
1
2019
695
0.130
 Why?
HIV Integrase Inhibitors
1
2018
78
0.120
 Why?
Feasibility Studies
2
2020
1095
0.120
 Why?
Leptin
3
2022
245
0.120
 Why?
Adverse Drug Reaction Reporting Systems
2
2007
81
0.120
 Why?
Pain
1
2022
782
0.120
 Why?
Forecasting
1
2018
391
0.120
 Why?
Travel
1
2017
136
0.120
 Why?
Dose-Response Relationship, Radiation
1
2016
140
0.120
 Why?
Precision Medicine
1
2020
458
0.120
 Why?
Prognosis
3
2020
4293
0.120
 Why?
Neoplasm Staging
1
2020
1465
0.120
 Why?
Anti-Inflammatory Agents
2
2018
475
0.120
 Why?
Hypertension
2
2018
1264
0.120
 Why?
Antimicrobial Stewardship
1
2018
130
0.120
 Why?
Fees, Pharmaceutical
1
2015
8
0.120
 Why?
Drug Administration Routes
1
2015
44
0.120
 Why?
Observational Studies as Topic
1
2016
129
0.120
 Why?
Arthroplasty, Replacement, Knee
1
2021
372
0.120
 Why?
Anti-Infective Agents
1
2018
242
0.110
 Why?
Anti-Retroviral Agents
1
2018
250
0.110
 Why?
Cross-Sectional Studies
6
2024
5872
0.110
 Why?
Cyclosporine
1
2016
265
0.110
 Why?
Hospital Mortality
1
2020
1031
0.110
 Why?
Pseudomonas Infections
1
2017
221
0.110
 Why?
Cause of Death
4
2023
472
0.110
 Why?
Logistic Models
2
2018
2119
0.110
 Why?
Recombination, Genetic
3
2005
205
0.110
 Why?
Health Care Costs
1
2018
427
0.110
 Why?
Inflammation Mediators
1
2017
509
0.110
 Why?
Obesity
2
2018
3082
0.110
 Why?
Cross Infection
1
2017
262
0.110
 Why?
Drug Administration Schedule
1
2016
783
0.110
 Why?
Glucocorticoids
1
2018
535
0.100
 Why?
Suicide
1
2021
720
0.100
 Why?
Health Expenditures
1
2015
194
0.100
 Why?
Guideline Adherence
1
2018
589
0.100
 Why?
Quality Improvement
1
2022
1291
0.100
 Why?
Infusions, Intravenous
1
2014
423
0.100
 Why?
Prednisone
3
2021
221
0.100
 Why?
Causality
1
2013
126
0.100
 Why?
Integrases
3
2005
122
0.100
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
40
0.090
 Why?
Adiposity
1
2017
543
0.090
 Why?
Telemedicine
1
2022
948
0.090
 Why?
Education, Medical, Continuing
1
2013
132
0.090
 Why?
Root Cause Analysis
1
2012
9
0.090
 Why?
Socioeconomic Factors
2
2018
1327
0.090
 Why?
Pneumonia
1
2018
631
0.090
 Why?
Mortality
1
2015
376
0.090
 Why?
HIV Infections
2
2018
3154
0.090
 Why?
Feedback
2
2023
181
0.090
 Why?
Occupational Injuries
1
2012
46
0.090
 Why?
Prescription Drug Misuse
1
2012
51
0.090
 Why?
Florida
1
2012
117
0.090
 Why?
Lung Diseases
1
2018
787
0.090
 Why?
HIV-1
1
2018
896
0.090
 Why?
Lung Neoplasms
2
2022
2642
0.090
 Why?
Narration
1
2012
75
0.080
 Why?
Osteoporotic Fractures
1
2012
61
0.080
 Why?
Outpatients
1
2014
443
0.080
 Why?
Health Personnel
1
2017
748
0.080
 Why?
Risk
1
2013
911
0.080
 Why?
Antineoplastic Agents
1
2022
2197
0.080
 Why?
Internal Medicine
1
2013
280
0.080
 Why?
Adolescent
5
2015
22453
0.080
 Why?
Reproducibility of Results
2
2016
3415
0.080
 Why?
Dose-Response Relationship, Drug
1
2014
2032
0.080
 Why?
Substance-Related Disorders
2
2023
1094
0.070
 Why?
Anti-Bacterial Agents
1
2020
1915
0.070
 Why?
Blood Pressure
2
2018
1769
0.070
 Why?
Young Adult
3
2015
14126
0.070
 Why?
Pattern Recognition, Automated
1
2008
74
0.070
 Why?
Sex Factors
3
2021
2114
0.070
 Why?
Diagnosis, Computer-Assisted
1
2008
91
0.070
 Why?
Hospital Records
1
2007
10
0.070
 Why?
Financing, Personal
1
2007
27
0.070
 Why?
Catheter-Related Infections
1
2008
94
0.070
 Why?
Cost Sharing
1
2007
20
0.070
 Why?
Antihypertensive Agents
1
2011
511
0.060
 Why?
Nonlinear Dynamics
1
2007
95
0.060
 Why?
Referral and Consultation
1
2013
853
0.060
 Why?
Biomarkers
3
2024
4275
0.060
 Why?
Mutagenesis, Site-Directed
2
2005
381
0.060
 Why?
Insulin-Like Growth Factor I
2
1999
319
0.060
 Why?
Viral Proteins
2
1999
355
0.060
 Why?
Machine Learning
2
2022
587
0.060
 Why?
Primary Health Care
2
2013
1734
0.060
 Why?
Drug Interactions
1
2007
401
0.060
 Why?
Respiratory Tract Diseases
2
2017
175
0.060
 Why?
Models, Theoretical
1
2008
582
0.050
 Why?
Health Services Research
1
2007
396
0.050
 Why?
Blotting, Southern
1
2004
85
0.050
 Why?
Data Collection
1
2007
635
0.050
 Why?
Chronic Disease
2
2022
1813
0.050
 Why?
Inpatients
2
2024
546
0.050
 Why?
Artificial Intelligence
1
2008
367
0.050
 Why?
Interleukin-17
1
2024
118
0.050
 Why?
Myocardial Infarction
1
2011
1209
0.050
 Why?
Mental Disorders
1
2012
1172
0.050
 Why?
Mass Screening
1
2012
1348
0.050
 Why?
Vital Capacity
1
2023
290
0.050
 Why?
Health Status
2
2018
836
0.050
 Why?
Odds Ratio
2
2018
1077
0.050
 Why?
Acetazolamide
1
2022
26
0.050
 Why?
Telomere Shortening
1
2022
19
0.050
 Why?
Antimanic Agents
1
2021
19
0.040
 Why?
Lithium
1
2021
42
0.040
 Why?
Valproic Acid
1
2021
48
0.040
 Why?
Medicare
1
2007
887
0.040
 Why?
Length of Stay
1
2007
1337
0.040
 Why?
Medication Therapy Management
1
2022
73
0.040
 Why?
Chlorambucil
1
2021
10
0.040
 Why?
Vidarabine
1
2021
32
0.040
 Why?
Bendamustine Hydrochloride
1
2021
17
0.040
 Why?
Bortezomib
1
2021
55
0.040
 Why?
Pulmonologists
1
2020
14
0.040
 Why?
Patient Discharge
2
2023
983
0.040
 Why?
Zebrafish
1
2005
528
0.040
 Why?
Data Display
1
2020
20
0.040
 Why?
Vincristine
1
2021
140
0.040
 Why?
Quality Control
1
2020
163
0.040
 Why?
Computed Tomography Angiography
1
2021
145
0.040
 Why?
Cerebrovascular Circulation
1
2022
280
0.040
 Why?
Pharmacists
1
2022
240
0.040
 Why?
User-Computer Interface
1
2020
165
0.040
 Why?
Embryonic and Fetal Development
1
1999
93
0.040
 Why?
Bone Marrow Transplantation
1
2020
294
0.040
 Why?
Piperidines
1
2021
217
0.040
 Why?
Range of Motion, Articular
1
2021
424
0.040
 Why?
Magnetic Resonance Imaging
2
2022
3869
0.040
 Why?
Magnetic Resonance Angiography
1
2021
251
0.040
 Why?
Telomere
1
2022
288
0.040
 Why?
Dexamethasone
1
2021
372
0.040
 Why?
Doxorubicin
1
2021
397
0.040
 Why?
Adenine
1
2021
339
0.030
 Why?
Gene Dosage
1
1998
148
0.030
 Why?
Patient Satisfaction
1
2022
705
0.030
 Why?
Cost-Benefit Analysis
1
2020
636
0.030
 Why?
Methicillin Resistance
1
2017
17
0.030
 Why?
Infant Mortality
1
1998
123
0.030
 Why?
Time-to-Treatment
1
2019
245
0.030
 Why?
Recurrence
1
2020
1135
0.030
 Why?
Gene Expression Regulation, Developmental
2
1999
906
0.030
 Why?
Reoperation
1
2020
631
0.030
 Why?
HIV Integrase
1
2018
74
0.030
 Why?
Rheumatic Nodule
1
2016
3
0.030
 Why?
Cardiovascular Agents
1
2018
164
0.030
 Why?
Absorptiometry, Photon
1
2017
276
0.030
 Why?
Isoxazoles
1
2016
54
0.030
 Why?
Thinness
1
2016
99
0.030
 Why?
Nutrition Surveys
1
2017
282
0.030
 Why?
Body Weight
2
2016
978
0.030
 Why?
Critical Illness
1
2022
892
0.030
 Why?
Rheumatoid Factor
1
2016
175
0.030
 Why?
Viral Load
1
2018
526
0.030
 Why?
Survival Analysis
1
2018
1385
0.030
 Why?
Community-Acquired Infections
1
2017
174
0.030
 Why?
Analysis of Variance
1
2018
1311
0.030
 Why?
Lymphoma
1
2016
233
0.030
 Why?
Peptides, Cyclic
1
2016
275
0.030
 Why?
Leukemia
1
2016
245
0.030
 Why?
Surveys and Questionnaires
2
2020
6053
0.030
 Why?
Life Style
1
2016
479
0.020
 Why?
Age Factors
1
2021
3335
0.020
 Why?
Quality of Health Care
1
2018
693
0.020
 Why?
Workers' Compensation
1
2012
28
0.020
 Why?
Tomography, X-Ray Computed
1
2023
2738
0.020
 Why?
Coroners and Medical Examiners
1
2011
8
0.020
 Why?
Sampling Studies
1
2011
99
0.020
 Why?
Death Certificates
1
2011
32
0.020
 Why?
Inflammation
1
2022
2880
0.020
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1958
0.020
 Why?
Brain
1
2022
2941
0.020
 Why?
Smoking
1
2016
1472
0.020
 Why?
Prostatic Neoplasms
1
2016
978
0.020
 Why?
Pancreatic Neoplasms
1
2016
927
0.020
 Why?
Medical Assistance
1
2007
13
0.020
 Why?
Models, Econometric
1
2007
34
0.020
 Why?
Psychoses, Substance-Induced
1
2007
15
0.020
 Why?
Deductibles and Coinsurance
1
2007
12
0.020
 Why?
Eligibility Determination
1
2007
68
0.020
 Why?
Evidence-Based Medicine
1
2011
732
0.020
 Why?
Quality of Life
1
2019
3192
0.020
 Why?
Costs and Cost Analysis
1
2007
220
0.020
 Why?
Child
1
2007
22657
0.020
 Why?
Delirium
1
2007
104
0.010
 Why?
Insurance Coverage
1
2007
239
0.010
 Why?
beta-Galactosidase
1
2005
77
0.010
 Why?
Blood Coagulation Disorders
1
2007
189
0.010
 Why?
HSP70 Heat-Shock Proteins
1
2005
76
0.010
 Why?
Mosaicism
1
2005
73
0.010
 Why?
Genes, Reporter
1
2005
276
0.010
 Why?
Animals, Genetically Modified
1
2005
250
0.010
 Why?
Sensitivity and Specificity
1
2008
1990
0.010
 Why?
Mice, Transgenic
2
1999
2185
0.010
 Why?
Case-Control Studies
1
2011
3608
0.010
 Why?
Recombinant Fusion Proteins
1
2005
675
0.010
 Why?
Hemorrhage
1
2007
809
0.010
 Why?
Liver
2
1999
1888
0.010
 Why?
Growth Disorders
1
1998
86
0.010
 Why?
Animals
3
2005
38109
0.010
 Why?
Mice
2
1999
18365
0.010
 Why?
RNA, Messenger
1
1998
2832
0.000
 Why?
Infant, Newborn
1
1998
6434
0.000
 Why?
Sauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (394) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)